Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics
Authors
Keywords
-
Journal
NATURAL PRODUCT REPORTS
Volume 32, Issue 2, Pages 328-347
Publisher
Royal Society of Chemistry (RSC)
Online
2014-10-02
DOI
10.1039/c4np00051j
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
- (2015) Patrick J. Grohar et al. NEOPLASIA
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone
- (2012) Carolyn N. Krasner et al. GYNECOLOGIC ONCOLOGY
- A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials
- (2012) Axel Le Cesne et al. INVESTIGATIONAL NEW DRUGS
- Hijacking a hydroxyethyl unit from a central metabolic ketose into a nonribosomal peptide assembly line
- (2012) C. Peng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meta-omic Characterization of the Marine Invertebrate Microbial Consortium That Produces the Chemotherapeutic Natural Product ET-743
- (2011) Christopher M. Rath et al. ACS Chemical Biology
- Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis
- (2011) Claudia Lebedinsky et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- XPF-Dependent DNA Breaks and RNA Polymerase II Arrest Induced by Antitumor DNA Interstrand Crosslinking-Mimetic Alkaloids
- (2011) Sascha Feuerhahn et al. CHEMISTRY & BIOLOGY
- A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group
- (2011) Sylvain Baruchel et al. EUROPEAN JOURNAL OF CANCER
- Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma
- (2011) Angela Cioffi et al. Expert Opinion on Drug Metabolism & Toxicology
- Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of homologous recombination in trabectedin-induced DNA damage
- (2008) M. Tavecchio et al. EUROPEAN JOURNAL OF CANCER
- Biosynthesis of 3-Hydroxy-5-Methyl-O-Methyltyrosine in the Saframycin/Safracin Biosynthetic Pathway
- (2008) Cheng-Yu Fu JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Synthetic Studies on Et-743. Assembly of the Pentacyclic Core and a Formal Total Synthesis
- (2008) Dan Fishlock et al. JOURNAL OF ORGANIC CHEMISTRY
- Transcription-coupled DNA Double-Strand Breaks Are Mediated via the Nucleotide Excision Repair and the Mre11-Rad50-Nbs1 Complex
- (2008) Josée Guirouilh-Barbat et al. MOLECULAR BIOLOGY OF THE CELL
- EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
- (2008) Leah A. Owen et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started